MedinCell S.A. Logo

MedinCell S.A.

MEDCL | PA

Overview

Corporate Details

ISIN(s):
FR0004065605
LEI:
969500R79U6PXCL2FF46
Country:
France
Address:
3 RUE DES FRERES LUMIERE, 34830 JACOU
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

MedinCell S.A. is a clinical and commercial-stage pharmaceutical company that develops a portfolio of long-acting injectable products across various therapeutic areas. The company's core activity involves combining its proprietary BEPO® technology with known active pharmaceutical ingredients to create innovative, extended-release treatments. MedinCell's business model focuses on developing these therapeutic solutions and licensing them to partners for commercialization. The company aims to optimize the efficiency and global accessibility of medical treatments, thereby enhancing and safeguarding patient health worldwide.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for MedinCell S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-17 17:45
Annual / Quarterly Financial Statement
Inside Information / News release on accounts, results
English 405.2 KB
2025-06-17 17:45
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 395.7 KB
2025-06-10 18:00
Report Publication Announcement
Inside Information / Other news releases
English 185.6 KB
2025-06-10 18:00
Report Publication Announcement
Informations privilégiées / Autres communiqués
French 192.0 KB
2025-06-06 18:00
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 183.7 KB
2025-05-28 18:00
Report Publication Announcement
Informations privilégiées / Autres communiqués
French 183.1 KB
2025-05-28 18:00
Regulatory News Service
Inside Information / Other news releases
English 156.6 KB
2025-05-28 17:45
Regulatory News Service
Inside Information / Other news releases
English 220.0 KB
2025-05-28 17:45
Earnings Release
Informations privilégiées / Autres communiqués
French 218.7 KB
2025-05-21 18:36
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
French 183.5 KB
2025-05-07 15:12
Earnings Release
Inside Information / Other news releases
English 227.6 KB
2025-05-07 15:12
Earnings Release
Informations privilégiées / Autres communiqués
French 217.5 KB
2025-04-22 18:11
Regulatory News Service
Informations privilégiées / Autres communiqués
French 194.3 KB
2025-04-22 18:11
Legal Proceedings Report
Inside Information / Other news releases
English 208.5 KB
2025-04-15 19:48
Regulatory News Service
Informations privilégiées / Autres communiqués
French 283.2 KB

Automate Your Workflow. Get a real-time feed of all MedinCell S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MedinCell S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-05-02 N/A Other Sell 60,000 600,006.00 EUR

Peer Companies

Company Country Ticker View
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden VICO
Vivoryon Therapeutics N.V. Logo
Develops small molecule therapies for severe age-related, inflammatory, and neurodegenerative diseases.
Germany VVY
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia N/A
Xintela AB Logo
Develops stem cell therapies and targeted antibody treatments for cancer and osteoarthritis.
Sweden XINT
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland XLS
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage therapeutics for autoimmune diseases.
Israel XTLB
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland YOS
Zealand Pharma Logo
Develops innovative peptide medicines for metabolic and rare diseases.
Denmark ZEAL
Ziccum AB Logo
Licenses drying tech for thermostable vaccines & biologics, eliminating the cold chain.
Sweden ZICC